Lexicon Pharmaceuticals, Inc. (LXRX)
NASDAQ: LXRX · Real-Time Price · USD
1.680
-0.030 (-1.75%)
At close: Mar 9, 2026, 4:00 PM EDT
1.650
-0.030 (-1.79%)
After-hours: Mar 9, 2026, 7:55 PM EDT

Lexicon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Net Income
--200.4-177.12-101.94-87.76
Upgrade
Depreciation & Amortization
-0.530.550.430.29
Upgrade
Other Amortization
-1.851.770.740.05
Upgrade
Loss (Gain) From Sale of Assets
---00.05
Upgrade
Loss (Gain) From Sale of Investments
--9.31-5.62--
Upgrade
Stock-Based Compensation
-13.514.3411.5210.58
Upgrade
Other Operating Activities
-0.811.51--
Upgrade
Change in Accounts Receivable
--2.46-0.98-0.010.38
Upgrade
Change in Inventory
-0.15-0.38--
Upgrade
Change in Accounts Payable
-14.86.450.08-14.16
Upgrade
Change in Other Net Operating Assets
-1.75-2.430.343.55
Upgrade
Operating Cash Flow
--178.78-161.9-88.85-87.02
Upgrade
Capital Expenditures
--1.03-0.47-1.33-1.22
Upgrade
Investment in Securities
--14.35-49.47-69.753.33
Upgrade
Investing Cash Flow
--15.38-49.94-71.082.11
Upgrade
Long-Term Debt Issued
--49.9648.87-
Upgrade
Long-Term Debt Repaid
-----11.7
Upgrade
Net Debt Issued (Repaid)
--49.9648.87-11.7
Upgrade
Issuance of Common Stock
-0.06138.8294.2137.08
Upgrade
Repurchase of Common Stock
--1.73-0.82-0.86-2.68
Upgrade
Other Financing Activities
--1.31---
Upgrade
Financing Cash Flow
-238.35187.96142.2122.71
Upgrade
Net Cash Flow
-44.19-23.88-17.72-62.2
Upgrade
Free Cash Flow
--179.81-162.37-90.18-88.24
Upgrade
Free Cash Flow Margin
--578.52%-13485.63%-64875.54%-29610.07%
Upgrade
Free Cash Flow Per Share
--0.56-0.73-0.54-0.61
Upgrade
Cash Interest Paid
-12.9210.062.290.8
Upgrade
Levered Free Cash Flow
--98.3-94.07-52.65-55.54
Upgrade
Unlevered Free Cash Flow
--90.41-87.66-51.65-55.09
Upgrade
Change in Working Capital
-14.242.660.4-10.23
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.